Inhibitory Effects of EGFR Antisense Oligodeox Ynucleotide in Human Colorectal Cancer Cell Line

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2002 Jan 31

PMID 11819687

Citations 9

Authors

Yong He

Jun Zhou

Jin-Sheng Wu

Ke-Feng Dou

Affiliations

Soon will be listed here.

Citing Articles

Splice-Switching Antisense Oligonucleotides Targeting Extra- and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer Cells.

Balachandran A, Raguraman P, Rahimizadeh K, Veedu R Biomedicines. 2023; 11(12).

PMID: 38137520 PMC: 10741442. DOI: 10.3390/biomedicines11123299.

Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model.

Zheng S, Zheng S, Huang F, Jiao C, Wu R World J Gastroenterol. 2007; 13(17):2484-9.

PMID: 17552033 PMC: 4146768. DOI: 10.3748/wjg.v13.i17.2484.

Kinase domain insert containing receptor promoter controlled suicide gene system selectively kills human umbilical vein endothelial cells.

Yang W, Huang Z, Lin L, Li Z, Yu J, Song H World J Gastroenterol. 2006; 12(33):5331-5.

PMID: 16981263 PMC: 4088200. DOI: 10.3748/wjg.v12.i33.5331.

Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.

Liu L, Zhang W, Jiang H, Zhu A, Wu L, Qi S World J Gastroenterol. 2002; 8(4):663-7.

PMID: 12174375 PMC: 4656317. DOI: 10.3748/wjg.v8.i4.663.

Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.

Yang J, Luo H, Lin Q, Liu Z, Yan L, Lin P World J Gastroenterol. 2002; 8(4):644-9.

PMID: 12174371 PMC: 4656313. DOI: 10.3748/wjg.v8.i4.644.

References

Neal D, Marsh C, Bennett M, Abel P, Hall R, Sainsbury J . Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet. 1985; 1(8425):366-8. DOI: 10.1016/s0140-6736(85)91386-8. View

Akino K, Ohtsuru A, Yano H, Ozeki S, Namba H, Nakashima M . Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant pituitary tumor progression and metastases in the rat. Cancer Res. 1996; 56(1):77-86. View

Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddings J . Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression. Cancer Res. 1996; 56(15):3499-507. View

Cohen S, Carpenter G, King Jr L . Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J Biol Chem. 1980; 255(10):4834-42. View

Teramoto T, Onda M, Tokunaga A, Asano G . Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer. Cancer. 1996; 77(8 Suppl):1639-45. DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1639::AID-CNCR33>3.0.CO;2-Z. View

Neckers L, Whitesell L, Rosolen A, Geselowitz D . Antisense inhibition of oncogene expression. Crit Rev Oncog. 1992; 3(1-2):175-231. View

Veale D, Ashcroft T, Marsh C, Gibson G, Harris A . Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer. 1987; 55(5):513-6. PMC: 2001730. DOI: 10.1038/bjc.1987.104. View

Cerutti J, Trapasso F, Battaglia C, Zhang L, Martelli M, Visconti R . Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. Clin Cancer Res. 1996; 2(1):119-26. View

Masui H, Kawamoto T, Sato J, Wolf B, Sato G, Mendelsohn J . Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res. 1984; 44(3):1002-7. View

10.

Wu X, Rubin M, Fan Z, DeBlasio T, Soos T, Koff A . Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. Oncogene. 1996; 12(7):1397-403. View

11.

Sainsbury J, Malcolm A, Appleton D, Farndon J, Harris A . Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol. 1985; 38(11):1225-8. PMC: 499417. DOI: 10.1136/jcp.38.11.1225. View

12.

Barnard J, Beauchamp R, RUSSELL W, DuBois R, Coffey R . Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology. 1995; 108(2):564-80. DOI: 10.1016/0016-5085(95)90087-x. View

13.

Rozengurt E . Growth factors, cell proliferation and cancer: an overview. Mol Biol Med. 1983; 1(1):169-81. View

14.

Ushiro H, Cohen S . Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem. 1980; 255(18):8363-5. View

15.

Sporn M, Roberts A . Autocrine growth factors and cancer. Nature. 1985; 313(6005):745-7. DOI: 10.1038/313745a0. View

16.

Abulafi A, Williams N . Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg. 1994; 81(1):7-19. DOI: 10.1002/bjs.1800810106. View

17.

Tong W, Ellinger A, Sheinin Y, Cross H . Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells. Br J Cancer. 1998; 77(11):1792-8. PMC: 2150335. DOI: 10.1038/bjc.1998.298. View

18.

Stein C, Cheng Y . Antisense oligonucleotides as therapeutic agents--is the bullet really magical?. Science. 1993; 261(5124):1004-12. DOI: 10.1126/science.8351515. View

19.

Bertram J, Killian M, Brysch W, Schlingensiepen K, Kneba M . Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides. Biochem Biophys Res Commun. 1994; 200(1):661-7. DOI: 10.1006/bbrc.1994.1499. View

20.

Masui H, Moroyama T, Mendelsohn J . Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes. Cancer Res. 1986; 46(11):5592-8. View